FDA aproves Clinolipid (Baxter) for Parenteral Nutrition
The FDA has on 4 October 2013, approved Clinolipid (lipid injectable emulsion, USP) from Baxter for intravenous feeding (Parenteral Nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink.Clinolipid was granted a priority review to help alleviate a drug shortage.
Clinolipid is a lipid emulsion that contains a mixture of refined olive oil and refined soybean oil. The fatty acids contained in Clinolipid serve as an important source of energy in patients receiving parenteral nutrition. The omega-3: omega-6 fatty acid ratio in Clinolipid has not been shown to improve clinical outcomes compared to other lipid emulsion products.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.